@eric341 I did a bit of “free” research for you because it seems you possibly don’t understand Bollinger bands from my last post. The extracts are taken from investopedia.com.
https://www.investopedia.com/terms/b/bollingerbands.asp“A squeeze signals a period of low volatility and is considered by traders to be a potential sign of future increased volatility and possible trading opportunities”
Assuming we get a positive announcement, it would be safe to assume a higher volatility in an increased share price position. Further more, the previous times RCE have contracted or “Squeezed” to a lower level of volatility we have seen similar breakout activity follow. I personally believe this new trading phase that we are currently in will be another one of these phases. I’ve posted before that the later quarter of this year hold significant milestones for RCE and by reading previous announcements about their compounds R327 and R529 I feel there will be more positive news to come. I’ve attached a chart identifying some of the contractions on RECCE followed by a breakout.I’m not giving out advice. And I’m certainly not giving it out to a person who quotes
“Always uprampers on every stock, ignore them unless the SP reinforces their views” because that my friend… doesn’t even make sense. Are you implying that its only worth listening to someone boast about a company when its share price is sitting at its peak? Because if you’re a trader that’s buying a stock when everyone is talking about it, then I would understand why your most important rule in investing would be to “Minimise your losses” as you quoted.
Schools out bro.
- Forums
- ASX - By Stock
- RCE
- Ann: Top 20 Shareholders Update
RCE
recce pharmaceuticals ltd
Add to My Watchlist
3.33%
!
31.0¢

Ann: Top 20 Shareholders Update, page-154
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
31.0¢ |
Change
0.010(3.33%) |
Mkt cap ! $89.39M |
Open | High | Low | Value | Volume |
31.0¢ | 32.0¢ | 30.0¢ | $25.76K | 82.29K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 13550 | 30.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
31.0¢ | 18938 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 13550 | 0.300 |
2 | 34803 | 0.295 |
2 | 50000 | 0.290 |
4 | 131061 | 0.285 |
10 | 251389 | 0.280 |
Price($) | Vol. | No. |
---|---|---|
0.310 | 18938 | 1 |
0.320 | 5000 | 1 |
0.325 | 12600 | 1 |
0.330 | 114230 | 1 |
0.350 | 51319 | 4 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
RCE (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online